Home LiteratureArticle Details
PMID: 18033300 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Nature ·Vol. 450 ·No. 7169 ·2007-11-22 ·Pages 566-9

Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA

Abstract

Regulatory T (T(reg)) cells are a critical sub-population of CD4+ T cells that are essential for maintaining self tolerance and preventing autoimmunity, for limiting chronic inflammatory diseases, such as asthma and inflammatory bowel disease, and for regulating homeostatic lymphocyte expansion. However, they also suppress natural immune responses to parasites and viruses as well as anti-tumour immunity induced by therapeutic vaccines. Although the manipulation of T(reg) function is an important goal of immunotherapy, the molecules that mediate their suppressive activity remain largely unknown. Here we demonstrate that Epstein-Barr-virus-induced gene 3 (Ebi3, which encodes IL-27beta) and interleukin-12 alpha (Il12a, which encodes IL-12alpha/p35) are highly expressed by mouse Foxp3+ (forkhead box P3) T(reg) cells but not by resting or activated effector CD4+ T (T(eff)) cells, and that an Ebi3-IL-12alpha heterodimer is constitutively secreted by T(reg) but not T(eff) cells. Both Ebi3 and Il12a messenger RNA are markedly upregulated in T(reg) cells co-cultured with T(eff) cells, thereby boosting Ebi3 and IL-12alpha production in trans. T(reg)-cell restriction of this cytokine occurs because Ebi3 is a downstream target of Foxp3, a transcription factor that is required for T(reg)-cell development and function. Ebi3-/- and Il12a-/- T(reg) cells have significantly reduced regulatory activity in vitro and fail to control homeostatic proliferation and to cure inflammatory bowel disease in vivo. Because these phenotypic characteristics are distinct from those of other IL-12 family members, this novel Ebi3-IL-12alpha heterodimeric cytokine has been designated interleukin-35 (IL-35). Ectopic expression of IL-35 confers regulatory activity on naive T cells, whereas recombinant IL-35 suppresses T-cell proliferation. Taken together, these data identify IL-35 as a novel inhibitory cytokine that may be specifically produced by T(reg) cells and is required for maximal suppressive activity.

MeSH Terms
Animals Cell Line Cell Proliferation Disease Models, Animal Flow Cytometry Forkhead Transcription Factors/metabolism Gene Expression Regulation Humans Inflammatory Bowel Diseases/metabolism Interleukin-12 Subunit p35/deficiency,genetics,metabolism Mice Mice, Inbred C57BL Minor Histocompatibility Antigens Receptors, Cytokine/deficiency,genetics,metabolism T-Lymphocytes, Regulatory/cytology,immunology,metabolism,transplantation
Chemicals
Ebi3 protein, mouse Forkhead Transcription Factors Foxp3 protein, mouse Il12a protein, mouse Interleukin-12 Subunit p35 Minor Histocompatibility Antigens Receptors, Cytokine
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Collison Lauren W
Department of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Workman Creg J
Kuo Timothy T
Boyd Kelli
Wang Yao
Vignali Kate M
Cross Richard
Sehy David
Blumberg Richard S
Vignali Dario A A
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2007-11-22
Pages
566-9
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com